- Datum06.05.2024
- Uhrzeit15:00 - 16:00 Uhr
- VeranstalterLYNX
Du willst selbst ins Charting einsteigen?
Nutze das Charting-Widget auf dem stock3 Terminal für Deine eigene Analyse. Mehr Features. Mehr Werkzeuge. Mehr stock3.
Chart im Terminal öffnenUnited Therapeutics Corp.(Del. Kurse
Name | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
---|---|---|---|---|---|---|
L&S | VK | |||||
Tradegate | VK | |||||
Stuttgart | VK |
Passende Produkte
WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
---|
Wertentwicklung (Nasdaq)
Wikifolio
Passender Service zu United Therapeutics Corp.(Del.
Webinar zu United Therapeutics Corp.(Del.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)204,440-262,510
- Jahrestief / Hoch ($)208,625-262,510
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von United Therapeutics Corp.(Del.
Termine von United Therapeutics Corp.(Del.
- Jul31United Therapeutics Corp.(Del.Q2 2024 Earnings Release
- Okt30United Therapeutics Corp.(Del.Q3 2024 Earnings Release
Beschreibung
United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.